Physician profile
Smitha Mathew
NPI 1922769868
$1,258.90
in general payments reported to CMS, 2019-2025
17 companies · $831 in 2025
The $831 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.02 · 2023: $29.72 · 2024: $373 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,233.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $300.00 | 2025 | Rapiblyk |
| Novartis Pharmaceuticals Corporation | $213.91 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $134.25 | 2024-2025 | Farxiga, Wainua |
| Alnylam Pharmaceuticals INC. | $131.34 | 2024-2025 | Onpattro, Amvuttra |
| Edwards Lifesciences Corporation | $65.02 | 2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.48 | 2024-2025 | Jardiance |
| Boston Scientific Corporation | $54.74 | 2022-2023 | Ekosonic, Eluvia |
| Cvrx, INC. | $50.56 | 2025 | Barostim Neo System |
| Abiomed | $49.33 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.78 | 2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $37.85 | 2025 | Optimizer |
| Pfizer INC. | $23.80 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $20.72 | 2024 | Arcalyst |
| Amgen INC. | $20.21 | 2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $19.88 | 2024 | Camzyos |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18.29 | 2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $13.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smitha Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.